Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite™, today...
Month: December 2022
Denis Arsenault Acquires Additional Securities of Jushi Holdings Inc.
HERGISWIL, Switzerland, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Denis Arsenault (the "Acquiror"), located at Rue Sonnhaldenstrasse, 1A, Hergiswil Switzerland, 6052,...
Smart for Life Announces Capital Restructuring Designed to Address Nasdaq Listing Requirements and Unlock Shareholder Value
Includes $1.0M Private Placement with Accredited Institutional Investors; and Conversion of $2.5M of Debt to Equity Restructuring Enhances Balance Sheet...
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
RAMSEY, N.J. and BOCA RATON, Fla., Dec. 09, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”),...
Timber Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards
BASKING RIDGE, NJ, Dec. 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a...
Israeli Biotech Clearmind Medicine Appoints ex-Red Bull Executive Special Advisor for Developing MEAI as Alcohol Substitute
Nicholas Kadysh, a former Red Bull Canada and Juul Labs Canada executive, is an expert on regulatory issues VANCOUVER, Dec....
Male Plus Uses Three Stimulating Ingredients
The Natural Libido-Enhancer Leans on the Natural Powers of Siberian Ginseng, Maca Root, and Tribulus TerrestrisFort Lauderdale, FL , Dec....
Male Plus Is Naturally Extending Intimate Times
The Health and Wellness Brand’s Libido-Enhancing Formula Combats the Distressing Side Effects of Premature EjaculationFort Lauderdale, FL, Dec. 09, 2022...
Signati™ Medical, Inc. Completes Acquisition of SuperiorVAS Intellectual Property and Technology
Providence, RI, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Signati™ Medical, Inc. today announced that it has completed the acquisition of all...
Cytokinetics Announces Availability of Briefing Documents for FDA Advisory Committee Meeting on Omecamtiv Mecarbil
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food...
HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series
TUCSON, Ariz., Dec. 09, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing...
Hydreight Technologies Inc. Reports Nine Months Ended September 30, 2022
Hydreight Technologies Inc. started trading under the symbol ‘NURS’ on the TSX Venture Exchange at market open on December 1,...
Optinose Announces Departure of Acting Chief Financial Officer
YARDLEY, Pa., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose...
Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib
Concurrent $100 million equity offering Naporafenib has a potential first-in-class and best-in-class profile in multiple RAS/MAPK pathway-driven tumors Pivotal-ready asset...
Erasca Announces Pricing of Underwritten Offering of Common Stock
SAN DIEGO, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab)
CAMBRIDGE, Mass., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced that the U.S. Food and Drug...
BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross proceeds
BBS-Bioactive Bone Substitutes Oyj, Company Announcement, 9 December 2022 at 2.15 p.m. EET BBS-Bioactive Bone Substitutes: 69% of the warrants...
ObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 9, 2022 –...
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
NEW YORK and MAINZ, GERMANY, DECEMBER 9, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced...
AMN Healthcare Receives Nation’s Highest Business Award for Diversity Achievement
Cary Grace, AMN Healthcare President and CEO Cary Grace is the new President and CEO of AMN Healthcare. DALLAS, Dec....